The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 354:109-112 January 12, 2006 Number 2
NextNext

Research in the Hot Zone
Robert Steinbrook, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Research conducted at biosafety level 4, popularly known as the hot zone, continues to be both revered and feared. Biosafety level 4 laboratories are the places to study dangerous and exotic agents that cannot safely be studied anywhere else, such as pathogens that can be transmitted within a laboratory through the air. This level of biosafety is often required for the development of diagnostic tests, therapies, and vaccines and as the starting point for work on newly recognized agents whose risks have yet to be established.1 At the same time, these laboratories are seen as potential targets of a terrorist . . . [Full Text of this Article]


Source Information

Dr. Steinbrook is a national correspondent for the Journal.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.